Literature DB >> 1975968

Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma.

K Watanabe1, M Nagai, S Wakai, T Arai, K Kawashima.   

Abstract

Gene deletion of chromosome 10 in 11 tumor tissues removed from nine patients with malignant glioma (seven glioblastomas and two malignant astrocytomas) was investigated. Loss of heterozygosity was found in four of the seven (57%) cases with glioblastoma, whereas heterozygosity was preserved in two malignant astrocytome cases. One glioblastoma case showed loss of heterozygosity only in the recurring tumor tissue, although heterozygosity was maintained in the initial tumor tissue. The significance of loss of heterozygosity in the growth and recurrence of glioblastoma is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975968     DOI: 10.1007/bf00294641

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Expression and rearrangement of the ROS1 gene in human glioblastoma cells.

Authors:  C Birchmeier; S Sharma; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Isolation and mapping of a polymorphic DNA sequence pMHZ15 on chromosome 10 [D10S17].

Authors:  M Hoff; Y Nakamura; R Payson; P O'Connell; M Leppert; G M Lathrop; J M Lalouel; R White
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

Review 5.  Oncogenes and neuro-oncology.

Authors:  I R Whittle
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

6.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

7.  Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma.

Authors:  J Trent; P Meltzer; M Rosenblum; G Harsh; K Kinzler; R Mashal; A Feinberg; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

8.  Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

Authors:  P Verde; M P Stoppelli; P Galeffi; P Di Nocera; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Human-tumor-derived cell lines contain common and different transforming genes.

Authors:  M Perucho; M Goldfarb; K Shimizu; C Lama; J Fogh; M Wigler
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

10.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

View more
  14 in total

Review 1.  Glial ontogeny and glial neoplasia: the search for closure.

Authors:  M E Linskey
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

2.  Loss of heterozygosity for DNA polymorphisms mapping to chromosomes 10 and 17 and prognosis in patients with gliomas.

Authors:  C E Jones; M B Davis; J L Darling; J F Geddes; D G Thomas; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

Review 3.  Genetic alterations in glioma and medulloblastoma.

Authors:  B K Rasheed; S H Bigner
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

Review 4.  Molecular biology of pediatric gliomas.

Authors:  C Raffel
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 5.  Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.

Authors:  Per Ø Sakariassen; Heike Immervoll; Martha Chekenya
Journal:  Neoplasia       Date:  2007-11       Impact factor: 5.715

6.  Interphase cytogenetics of glioblastoma and gliosarcoma.

Authors:  W Paulus; A Bayas; G Ott; W Roggendorf
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 7.  Genetic alterations associated with the evolution and progression of astrocytic brain tumours.

Authors:  H Ohgaki; B Schäuble; A zur Hausen; K von Ammon; P Kleihues
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10.

Authors:  A E Karlbom; C D James; J Boethius; W K Cavenee; V P Collins; M Nordenskjöld; C Larsson
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

9.  Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis.

Authors:  U Diedrich; J Lucius; E Baron; J Behnke; B Pabst; B Zoll
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

10.  Loss of alleles in brain tumours: distribution and correlations with clinical course.

Authors:  U Diedrich; J Lucius; H J Bittermann; M Schlösser; B Eckert; J Behnke; B Pabst
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.